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Several studies have recently demonstrated the existence of human T-cell leukemia virus type 1 (HTLV-1)
antisense transcripts, which allow the synthesis of the newly described HBZ protein. Although previous reports
have been aimed at understanding the potential role of the HBZ protein in HTLV-1 pathogenesis, little is
known as to how this viral gene is regulated. Here, using our K30-3asLuc reporter construct, we show that the
viral Tax protein upregulates antisense transcription through its action on the TRE sequences located in the
3 long terminal repeat. Generation of stable clones in 293T cells demonstrated that Tax-induced HBZ
expression is importantly influenced by the integration site in the host genome. The cellular DNA context could
thus affect the level of HBZ mRNA expression in infected cells.
Human T-cell leukemia virus type 1 (HTLV-1) is the etio-
logical agent of adult T-cell leukemia/lymphoma (ATLL) and
HTLV-1-associated myelopathy, also known as tropical spastic
paraparesis (13, 29, 34, 35, 37, 46), leading to disease develop-
ment in less than 5% of infected individuals (42). The HTLV-1
Tax protein is generally considered to play a central role in the
viral pathogenesis, although its precise function remains to
be determined. Tax transactivates the viral promoter,
mainly through three Tax responsive element 1 (TRE1) re-
peats located in the U3 region of the 5 long terminal repeat
(LTR) (14, 15, 17, 19, 44). Each TRE1 repeat contains an
imperfect cyclic AMP response element (CRE), and they are
crucial for both basal and Tax-induced promoter activity (14,
15, 17, 19, 44). Tax associates with TRE1-bound ATF/CREB
transcription factors and recruits the transcriptional coactiva-
tor CBP/p300, which results in a strong transcriptional activa-
tion (12, 22). Tax also upregulates the expression of cellular
genes through the activation of several transcription factors,
such as CREB-1, NF-B and SRF (1, 30, 45).
Recently, we (6) and others (31, 39) have clearly demon-
strated the existence of antisense transcripts in HTLV-1, which
initiate from the 3 LTR. These transcripts are alternatively
spliced and encode the newly described HTLV-1 bZIP factor
(HBZ) through an ATG initiation codon being present in exon
1 located in the 3 LTR. Interestingly, HBZ downregulates the
Tax-dependent transactivation of viral gene expression
through the formation of heterodimers with CREB-1 and
CREB-2. In addition, HBZ interacts with c-Jun, JunB, and
JunD and modulates their transcriptional activities (4, 24, 41).
Recent studies have shown that HBZ is expressed in all ATL
cell lines, suggesting that it might play an unsuspected role in
the biological process leading to ATLL development (28, 43).
Despite the increasing number of studies aimed at under-
standing the role of HBZ in viral pathogenesis, little is known
about the promoter region regulating its expression. In order
to clarify this issue, we have performed several transfection
experiments using our previously described K30-3asLuc con-
struct (6). In this construct, a cassette containing the luciferase
reporter gene and the simian virus 40 poly(A) signal was
cloned in the antisense orientation in a 5 LTR-deleted version
of the full-length HTLV-1 K30 proviral DNA. More precisely,
the luciferase reporter gene lies downstream of the 5 end of
HBZ exon 2 while remaining in frame of the HBZ open read-
ing frame. Jurkat cells were transiently transfected with K30-
3asLuc by electroporation (250 V, 950 F) and stimulated or
left untreated for 8 h with different T-cell activators. At 16 h
posttransfection, luciferase activity was measured as previ-
ously described (20). The antisense promoter was shown to
be inducible in stimulated Jurkat cells by phytohemagglutinin
and phorbol myristate acetate but also, more importantly, by a
combination of the protein tyrosine phosphatase inhibitor
bpV[pic] and forskolin (Fig. 1A) (20). Since bpV[pic]/forskolin
treatment has been previously shown to upregulate HTLV-1
sense gene expression by activating CREB transcription factors
(32, 36), these results suggested a possible role for this tran-
scription factor in antisense promoter activity. We next trans-
fected various HTLV-1-infected T-cell lines with K30-3asLuc
along with the -galactosidase-expressing plasmid pRc-actin-
LacZ by using the same electroporation conditions as those
described above. The -galactosidase activity was measured
using the Galacto-Light kit (Applied Biosystems, Bedford,
MS). Interestingly, the results suggested that antisense pro-
moter activity was higher in HTLV-1-infected cells than in
noninfected Jurkat cells, with the exception of the Tax-nonex-
pressing S1T cell line (23). A strong luciferase signal was ob-
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tained for virion-producing cell lines MT-2 and C91/PL, while
MJ cells, which produce less viral particles (unpublished data),
showed lower luciferase activity. In addition, non-HTLV-1-
producing Tax-expressing C8166-45 cells (5) showed a signal
comparable to the one obtained with the MT-2 and C91/PL
cells (Fig. 1B). Hence, these results suggested a possible im-
plication of the Tax protein on the regulation of antisense
promoter activity. To test this potential implication of Tax,
levels of Tax protein were evaluated. Cell extract preparation
and Western blot analysis were conducted as previously de-
scribed (6). Using our anti-Tax antibody (dilution, 1/100) (2)
along with a horseradish peroxidase-coupled anti-mouse im-
munoglobulin G (1/10,000) (Santa Cruz Biotechnology Inc.,
Santa Cruz, CA), Tax was detected in C8166-45, C91/PL, and
MT-2 cells (Fig. 1C). In MT-2 cells, a 68-kDa protein was
detected and corresponded to a previously identified Tax-Env
fusion protein, which has been suggested to be also function-
ally active (7, 18). No specific band could be detected for the
MJ, S1T, and Jurkat cell lines. Equal loads of extracts were
confirmed with GAPDH (glyceraldehyde-2-phosphate dehydro-
genase) by using a mouse anti-GAPDH antibody (1/1,000; Santa
Cruz Biotechnology Inc.). The absence of a Tax-specific band
in MJ cells was most likely due to low expression level, since
reverse transcriptase PCR (RT-PCR) confirmed the pres-
ence of Tax mRNA in this cell line (data not shown).
As the presence of Tax correlated with high levels of
antisense transcription-driven luciferase activity, we then
performed several cotransfection experiments with 293T
and Jurkat cells (as outlined in reference 6). In both cell types,
cotransfection of a Tax expression vector, pTax (25), and K30-
3asLuc resulted in a statistically significant increase in lucif-
erase activity compared to the control (Fig. 2A). Because LTR-
driven transcription is differently regulated in a plasmidic
context in comparison to the chromatin context (27, 33), the
effect of Tax expression on antisense promoter activity was
further evaluated in an integrated proviral DNA. As initial
RT-PCR experiments indicated the presence of HBZ spliced
mRNA in Tax-nonproducing S1T cells, S1T cells were thus
electroporated (see conditions described above) with a Tax-
expressing vector (versus pHPr.1neo) and analyzed for the
FIG. 1. HTLV-1 antisense promoter activity in stimulated Jurkat cells and HTLV-1-infected cells. (A) Jurkat cells were transfected with 15 g
of K30-3asLuc and stimulated for 8 h with various T-cell-activating agents (3 g/ml phytohemagglutinin, 20 ng/ml phorbol myristate acetate, 1 M
ionomycin, 15 M bpV[pic], 10 M forskolin, 20 ng/ml tumor necrosis factor alpha [TNF-]) at 16 h posttransfection or left untreated (no
stimulation [NS]). Cells were monitored for luciferase activity. Luciferase activity values are presented as the means  standard deviations (SD)
of the results for triplicates. Student’s t tests were performed to determine significant differences between samples and the unstimulated control.
*, P  0.05; **, P  0.01. (B) Jurkat cells and various HTLV-1-infected cells were transfected with 15 g K30-3asLuc along with 4 g
pRc-actin-LacZ. Cells were lysed 24 h posttransfection and monitored for luciferase and -galactosidase activities. Luciferase values are presented
as the means  SD of the results for triplicates and are expressed as normalized RLU (RLU/-galactosidase). (C) The amount of Tax protein
expressed in each cell line was assessed by Western blotting. Detection of GAPDH is shown as a loading control.
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presence of the major HBZ spliced transcript by RT-PCR.
PCR amplifications were conducted on oligo(dT)-primed cDNAs
with a forward primer spanning the HBZ mRNA splice junc-
tion (5-ATGGCGGCCTCAGGGCTGT-3) and a reverse
primer located in the HBZ coding region (5-TGGAGGGCC
CCGTCGCAG-3) and with -actin-specific primers (5-CGT
GACATTAAGGAGAAGCTG-3 and 5-CTCAGGAGGAGC
AATGATCTT-3). PCR conditions were as follows: a first step of
denaturation at 95°C for 10 s, followed by 35 (standard) or 50
(real-time) cycles of denaturation (94°C for 3 s), annealing
(60°C for 15 s), and elongation (72°C for 12 s). Real-time
RT-PCR experiments were performed under these conditions
using the SYBR Premix Ex Taq (perfect real time) kit. The
HPRT-1 gene served as the internal control with the following
forward and reverse primers: 5-AAGCTTGCGACCTTGAC
C-3 and 5-GACCAGTCAACAGGGGACATAA-3. Both
real-time and standard semiquantitative RT-PCR experi-
ments showed a significant increase in HBZ mRNA level in
the Tax-transfected S1T cells, thus confirming the results
obtained with our luciferase reporter construct (Fig. 2B
and C).
Since electroporation of S1T cells resulted in about 5 to 10%
of transfected cells (data not shown) and might account for the
low level of induction, 293T cells were next stably transfected
with K30-3asLuc and pCMV-Hyg at a 10:1 ratio using Lipo-
fectamine 2000 (Invitrogen). Individual clones were selected in
the presence of 200 g/ml hygromycin B and then tested for
luciferase activity. As shown in Fig. 3A, we first noted impor-
tant variations in basal luciferase activities in the different
clones (from 1 to 5,564 relative light units [RLU]), suggesting
that the integration sites importantly influenced the basal ac-
tivity of the HBZ promoter. Transfection of the 293T cell
clones with pTax resulted in an important induction of lucif-
erase activity, reaching activity levels increased up to 2,000-fold
for certain clones (Fig. 3B). The observed Tax inductions were
generally inversely correlated with basal luciferase activity lev-
els of the different clones.
Assessment of integrated plasmidic DNA copy numbers was
then conducted by real-time PCR on 100 ng of genomic DNA
of the different clones using luciferase-specific forward (5-TG
TTGTTCCATTCCATCACG-3) and reverse (5-TGGCGA
AGAAGGAGAATAGG-3) primers (Fig. 3C). Each DNA
sample was normalized with the HPRT-1 control gene ampli-
fication. A standard curve was similarly amplified in parallel
and consisted of 4.7 	 103 to 4.7 	 107 copies of pGL3basic
DNA diluted in 100 ng of nontransfected 293T genomic DNA.
Results showed variations in the normalized copy numbers
among the different clones, ranging from 3,200 to 14,300 cop-
ies/ng of genomic DNA, but these variations did not correlate
with basal or Tax-induced levels of luciferase activity, indicat-
ing that the number of integrated plasmids was not responsible
for the observed differences in luciferase activity levels. In
parallel, Western blot analyses were carried out using mouse
anti-CREB-1 and anti-CREB-2 antibodies (1/500; Santa Cruz
Biotechnology Inc.). Results showed weak variations in the
expression of these transcription factors in the different clones
(Fig. 3D).
To better understand this Tax-dependent upregulation of
HBZ gene expression, two representative clones (8 and 21)
were transfected with vectors expressing various Tax mutants
(11, 38). Compared to the Tax-mediated increase in luciferase
gene expression, Tax M47 and Tax K88A mutants (deficient
FIG. 2. Upregulation of antisense transcription by the viral Tax protein. (A) 293T and Jurkat cells were transfected with 500 ng of K30-3asLuc,
200 ng of pRc-actin-LacZ, and 300 ng of pTax or the empty vector pHPr.1neo. Cells were lysed 48 h posttransfection and monitored for luciferase
and -galactosidase activities. Data for luciferase activity represent the mean values  SD of the results for three measured samples and are
expressed as normalized RLU (RLU/-galactosidase). (B and C) S1T cells were electroporated with 15 g of pTax or pHPr.1neo. Total RNA
was isolated 48 h posttransfection, and the HBZ spliced mRNA was amplified by standard (B) or real-time (C) RT-PCR, using -actin or HPRT-1
as an internal control, respectively. These results are representative of three independent experiments and are presented in independently
transfected triplicates. Student’s t tests were performed to determine significant differences between the samples (*, P  0.05; **, P  0.01).
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for CREB-dependent transcriptional activation and CBP/p300
recruitment, respectively) resulted in a more limited increase
in the activation of luciferase activity. In contrast, an NF-B
activation-defective Tax (Tax M22) or a PDZ binding-motif-
mutated Tax (Tax 
PBM) led to levels of induction compara-
ble to those of wild-type Tax-transfected cells (Fig. 3E). De-
tection of Tax protein levels using a Tax antiserum (1/1,000;
NIH AIDS Research and Reference Reagent Program, Ger-
mantown, MD) and horseradish peroxidase-conjugated anti-
rabbit immunoglobulin G (1/10,000; Santa Cruz Biotechnology
Inc.) demonstrated that the low induction levels observed for
the M47 and K88A mutants could not be attributed to a lower
protein expression (Fig. 3F). These results therefore suggested
that Tax induction of the antisense promoter requires the par-
ticipation of CREB.
In order to confirm that CREB can directly modulate
HBZ promoter activity, expression vectors for wild-type
CREB, a constitutively active CREB mutant (CREB-FY)
(9) and CREB-2 (10) were transfected into stable 293T cell
clones 8 and 21 or into pooled, stably transfected 293T cells.
Results demonstrated that both wild-type CREB and CREB-FY
could potently increase luciferase activity, albeit at a lower
level than the one observed when Tax is expressed. On the
other hand, CREB-2 repressed luciferase gene expression to
levels lower than those of the basal activity (Fig. 4A). The
negative effect of CREB-2 on the antisense promoter is not
FIG. 3. Tax-induced antisense promoter activity is influenced by the integration site. (A) 293T cells were stably transfected with 4 g
K30-3asLuc and 400 ng pCMV-Hyg. Different clones and a pool of clones were measured for luciferase activity. Data for luciferase activity
represent the mean value  SD of the results for three measured samples. (B) Pooled clones and different 293T cell clones were transfected with
800 ng of pTax or the empty vector and monitored for luciferase activity 48 h after transfection. Results are presented as the amount of increase
in normalized luciferase activity measured for Tax-expressing cells over the activity of cells transfected with the control vector. (C) Real-time PCR
amplification of the luciferase gene was conducted in order to quantify the integrated plasmid copy number in each clone. Results were normalized
with the HPRT-1 gene and are shown as the number of copies per nanogram of genomic DNA. (D) Western blot analysis for CREB-1, CREB-2,
and GAPDH (loading control) was performed on 50 g of total protein extracts from each 293T cell clone. (E) Two stable K30-3asLuc clones
were transfected with 800 ng pSG-Tax, pSG-Tax M22, pSG-Tax M47, pSG-Tax K88A, pSG-Tax 
PBM, or the empty pSG-5 vector. Cells were
lysed 48 h posttransfection and monitored for luciferase activity. Data for luciferase activity represent the mean values SD of the results for three
measured samples. (F) Tax levels from each expression vector were assessed by Western blot analysis using Tax antiserum. GAPDH levels were
analyzed as a control.
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surprising, as this transcriptional factor has been reported to
repress the expression of cellular genes containing CREs in
their promoter (16). It is likely that CREB-2 on its own down-
regulates antisense transcription by interacting with CBP/p300,
thus preventing it from binding transcription factors positioned
on the 3 LTR, although it might have a positive role in the
presence of Tax, as previously reported (10).
Based on the above-described CREB-1-dependent upregu-
lation of luciferase expression in our stably transfected clones,
the 3 LTR sequence of K30-3asLuc was replaced with an
LTR mutated in the TRE1 repeats to be unable to bind to
CREB (3), thereby generating K30-3asLuc 21PMD. These
constructs were transiently cotransfected into 293T cells with
our Tax expression vector (Fig. 4B). While no major differ-
ences were observed in basal luciferase activity between the
samples, the K30-3asLuc 21PMD-transfected cells showed a
dramatically reduced response to Tax compared to those trans-
fected with the wild-type construct. 293T cells were then stably
transfected with the wild-type or TRE1-mutated K30-3asLuc
constructs (Fig. 4C). Tax expression in both cell populations
demonstrated results similar to those presented above, further
suggesting that TRE1 repeats were required for optimal Tax-
mediated activation of HBZ expression. These results are thus
in agreement with a previous study that demonstrated the
nearly equal capacities of the 5 LTR and the 3 LTR to bind
transcription factors and coactivators in HTLV-1-infected cell
lines and ATL cells (21).
To further confirm the role of CREB in Tax-induced HBZ
expression in the proviral DNA context, ACH proviral DNA
expressing either wild-type Tax (ACH-Tax) or the Tax M47
mutant (ACH-Tax M47) were cotransfected into 293T cells
along with pTax or the empty vector (Fig. 4D). The relative
level of HBZ mRNA was then analyzed by real-time RT-PCR.
In the absence of pTax, the mutated ACH-Tax M47 proviral
FIG. 4. Positive regulation of the antisense promoter by CREB. (A) Two 293T cells clones stably transfected with K30-3asLuc and the isolated
pool were transfected with 800 ng of expression vectors for CREB, CREB-FY, or CREB-2 or the empty vector. Cells were lysed 48 h
posttransfection and monitored for luciferase activity. Data for luciferase activity represent the mean values SD of the results for three measured
samples. (B) 293T cells were transfected with 500 ng of K30-3asLuc or K30-3asLuc 21PMD, 200 ng pRc-actin-LacZ, and 300 ng of pTax (versus
pHPr.1neo). Cells were lysed 48 h posttransfection and monitored for luciferase and -galactosidase activities. Data for luciferase activity
represent the mean values SD of the results for three measured samples and are expressed as normalized RLU (RLU/-galactosidase). (C) 293T
cells stably transfected with K30-3asLuc or K30-3asLuc 21PMD were transfected with 800 ng of pTax or pHPr.1neo. Cells were lysed 48 h
posttransfection and monitored for luciferase activity. Data for luciferase activity represent the mean values SD of the results for three measured
samples. (D) Wild type- or Tax M47-expressing ACH proviral DNA (500 ng) was transfected into 293T cells with 200 ng of pRc-actin-LacZ and
300 ng of pTax or pHPr.1neo. HBZ mRNA expression levels were quantified by real-time RT-PCR, using the HPRT-1 gene as a reference
control. *, P  0.05; **, P  0.01.
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DNA showed a significantly reduced level of HBZ mRNA
compared to wild-type ACH-Tax. On the other hand, Tax
expression resulted in an important increase in HBZ mRNA
levels in both ACH-Tax and ACH-Tax M47 samples, confirm-
ing the modulator role of Tax in antisense transcription. No
significant difference could be observed between the ACH-Tax
and ACH-Tax M47 samples when a Tax expression vector was
cotransfected, most likely because the level of Tax protein
produced from the expression vector importantly exceeds the
one expressed from the proviral DNA.
The results presented in this study are important informa-
tion for the understanding of HTLV-1 replication and patho-
genesis. First, we provide evidence that Tax can control the
expression of its viral repressor, HBZ, which is in agreement
with a recent study (47). The existence of such a retroaction
loop controlling the TAX/HBZ expression balance should pre-
vent exaggerated Tax expression, which could ultimately lead
to a strong and unfavorable anti-Tax immune response. In
addition, our results show that the Tax-dependent induction of
antisense promoter activity importantly depends on the inte-
gration site. The more pronounced Tax-dependent induction
in 293T cell clones with low basal promoter activity might be
consequential to the recently described capacity of Tax to
induce the disassembly of nucleosomes at the viral promoter
(40). In contrast, strong basal HBZ promoter activity would
probably be associated with a favorable chromatin context,
which would further explain the reduced upregulation medi-
ated by Tax.
Recent studies have shown that HTLV-1 integrates ran-
domly in the host genome (8), although integration in tran-
scriptionally active units could be associated with HTLV-1-
associated myelopathy/tropical spastic paraparesis development
(26). One could equally hypothesize that integration into a
transcriptionally active site of the genome would affect the
sense/antisense transcriptional balance in favor of HBZ ex-
pression, a feature that appears to be characteristic of ATL
cells, according to another recent study (43). In conclusion, our
results demonstrate that Tax plays an important role in regu-
lating HBZ expression. Further analyses are warranted to bet-
ter understand the regulation of HBZ expression and how this
might act upon transformation of HTLV-1-infected cells and
consequently ATLL development.
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